Recent Updates
Recently added Catalysts
GCTK Positive Sentiment

Glucotrack Announces $5.5 Million Financing

Wednesday, August 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Glucotrack, Inc. has announced definitive agreements for approximately $5.5 million in financing. This funding includes a $2.0 million equity financing priced at $0.75 per unit and a $3.5 million follow-on investment in convertible debt. The participation of institutional investors highlights the company's potential and market confidence.
Price reaction · baseline $0.5986 (2026-08-04 close) · hit pre-market · clean, no other GCTK news in the window
day 0 close
-12.3%
day 1
-21.2%
day 3 · peak
-32.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Secured $5.5 million in financing.
  • Includes both equity and convertible debt investments.
  • Participation from institutional investors indicates confidence.

Full Press Release Details

RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack, Inc. (NASDAQ: GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for approximately $5.5 million in financing from participating institutional investors, including a $2.0 million equity financing priced at $0.75 per unit and a $3.5 million follow-on investment in the form of convertible debt. The equity financing consists of units priced at $0.75 per unit, with each unit comprised of one share of common st

Frequently Asked Questions

What is the total financing amount announced by Glucotrack?

Glucotrack announced approximately $5.5 million in financing.

What types of financing did Glucotrack secure?

The financing includes $2.0 million in equity and $3.5 million in convertible debt.

What is the price per unit for the equity financing?

The equity financing is priced at $0.75 per unit.

Who are the investors involved in Glucotrack's financing?

The financing involves participation from institutional investors.

ShareAdd on Google
Tags: GCTK financing equity investment convertible debt institutional investors
Last updated: Aug 5, 2026

Biotech snapshot

Cash runway
$1M liquidity · $1M/mo burn
~0 mo
High dilution risk